Jim Simons Ice Cure Medical Ltd. Transaction History

Renaissance Technologies LLC

  • $62.3 Billion
  • Q1 2025

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$0.53 - $1.16 $5,777 - $12,644
10,900 New
10,900 $11,000
Q2 2024

Aug 09, 2024
BUY
$0.74 - $1.35 $49,136 - $89,640
66,400 New
66,400 $49,000
Q4 2023

Feb 13, 2024
BUY
$0.72 - $1.36 $11,880 - $22,440
16,500 New
16,500 $18,000
Q2 2023

Aug 11, 2023
BUY
$1.06 - $1.4 $20,034 - $26,460
18,900 New
18,900 $22,000

Others Institutions Holding ICCM

# of Institutions
17
Shares Held
161K
Call Options Held
0
Put Options Held
0
View Full List

About IceCure Medical Ltd.

ICCM Quotes by TradingView
  • Ticker ICCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 36,835,600
  • Market Cap $38.3M
  • Description
  • IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
More about ICCM
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email